Low-frequency Raman spectra ͑up to 800 cm Ϫ1 ) measured below 18 K are reported for the entire pressure range of phase I of para-hydrogen doped with low fractions of the ortho-modification. In addition to bands corresponding to the E 2g optical phonon and the Jϭ2←0 rotational transitions, we observed a weak band attributed as S 0 (1). These spectra are employed to deduce information on the interactions that play a decisive role in bringing about the transition to the broken symmetry phase II. A new theoretical analysis is presented to understand the rotational Raman excitations and the role of various pairwise anisotropic interactions between H 2 molecules. In order to explain the pressure dependence of the S 0 (0) and S 0 (1) bands, we infer that a fourth-harmonic crystal field is present. The frequencies of the S 0 (0) and S 0 (1) bands are used to reconstruct the respective crystal field parameter.
Details of the crystal structure and quantum chemistry calculations of the title molecule, C13H9BrO, illustrate the effects of intermolecular interactions and the substitution of one of the two aromatic rings on the molecular conformation. The asymmetry of the molecule is documented by the two Caryl—Caryl—C=O torsion angles of −68.3 (5) and −17.6 (6)°. A C—H·O hydrogen bond [H·O = 2.5 Å, C·O = 3.412 (5) Å and C—H·O = 174°] and a C—H·π contact involving the H atom at position 4 of the substituted ring and the π‐system of the unsubstituted ring of an adjacent molecule [H·Cg = 2.96 Å, C·Cg = 3.806 (5) Å and C—H·Cg = 153°; where Cg is the centroid of the unsubstituted ring] are observed in the crystal structure.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.